In what conditions are burr cells present?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: August 15, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Burr Cells: Clinical Significance and Associated Conditions

Burr cells (echinocytes) are primarily present in uremia/chronic kidney disease, hemolytic uremic syndrome, and certain other conditions including liver disease, malnutrition, and specific medication exposures.

Definition and Morphology

Burr cells (echinocytes) are red blood cells with multiple, evenly spaced, small projections distributed across the cell membrane. They appear spiculated with short, blunt projections that give them a characteristic "burr-like" appearance on peripheral blood smear.

Primary Clinical Conditions Associated with Burr Cells

1. Renal Conditions

  • Uremia/Chronic Kidney Disease (CKD)

    • Most common association with burr cells 1
    • Uremic toxins alter the lipid composition of red cell membranes
    • Severity of burr cell formation often correlates with degree of renal dysfunction
    • Associated with increased mortality in hospitalized patients (27.3% 30-day mortality) 2
  • Hemolytic Uremic Syndrome (HUS)

    • Characterized by microangiopathic hemolytic anemia with burr cells and other RBC fragments 1
    • Typically follows acute gastrointestinal illness (usually diarrheal)
    • Associated with acute renal injury, thrombocytopenia

2. Liver Disease

  • Alcoholic Liver Disease
    • Can cause severe hemolytic anemia with burr cell formation 3
    • May be associated with altered lipid composition of RBC membranes
    • Often improves with alcohol cessation, though complete resolution may take months

3. Medication/Treatment-Related

  • Parenteral Fish Oil Therapy
    • Reported to cause burr cell anemia in infants with short bowel syndrome 4
    • Reversible upon discontinuation of parenteral fish oil

4. Other Conditions

  • Malnutrition
  • Pyruvate kinase deficiency
  • Post-splenectomy
  • Burns

Pathophysiological Mechanisms

The formation of burr cells typically involves:

  1. Membrane Lipid Alterations:

    • Changes in phospholipid composition, particularly phosphatidylserine and phosphatidylinositol 3
    • Altered cholesterol-to-phospholipid ratio in some cases
  2. Oxidative Stress:

    • Particularly important in uremia where increased oxidative stress damages RBC membranes 5
    • Activation of ROS and MAPK/NF-κB pathways
  3. Uremic Toxins:

    • Direct effect on RBC membrane structure
    • Indoxyl sulfate, p-cresol, and other uremic toxins contribute to membrane damage 5

Clinical Significance

  1. Prognostic Value:

    • Independent predictor of 30-day mortality in hospitalized patients 2
    • 3-fold increase in mortality risk when present on admission
  2. Diagnostic Value:

    • Indicator of underlying disease processes
    • May help identify renal or liver dysfunction
    • Part of the diagnostic criteria for hemolytic uremic syndrome 1

Management Implications

The presence of burr cells should prompt:

  1. Evaluation of renal function:

    • Serum creatinine, BUN, GFR assessment
    • Urinalysis for hematuria and proteinuria
  2. Assessment for hemolysis:

    • Complete blood count with peripheral smear review
    • Reticulocyte count, LDH, haptoglobin, and indirect bilirubin
  3. Treatment of underlying condition:

    • Management of renal or liver disease
    • Discontinuation of causative medications if identified
    • Supportive care for hemolytic anemia if present

Conclusion

Burr cells serve as important morphological markers of several serious conditions, most notably uremia/chronic kidney disease and hemolytic uremic syndrome. Their presence on peripheral blood smear should prompt thorough investigation of renal function and evaluation for hemolysis, as they are associated with increased mortality and may indicate significant underlying pathology.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Parenteral fish oil-associated burr cell anemia.

The Journal of pediatrics, 2010

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.